Phio Pharmaceuticals Corp.

Ownership Transactions Reported by 10 Insiders

Symbol
PHIO on Nasdaq
Industry
Pharmaceutical Preparations
Location
11 Apex Drive, Suite 300 A, Pmb 2006, Marlborough, MA

Insiders trading volume in the past year

Phio Pharmaceuticals Corp. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gerrit Dispersyn President & CEO, Director $321K Mar 1, 2022
H. Paul Dorman Director $30.8K Feb 15, 2022
Robert J. Bitterman Chairman, Pres & CEO, Director $13.2K +$3.77K +39.9% Sep 11, 2024
Caitlin Kontulis Secretary & VP Finance & Admin $10.2K Mar 1, 2024
Robert M. Infarinato Vp, Cfo $8.14K Sep 11, 2024
Robert L. Ferrara Director $7.4K Sep 11, 2024
Geert Cauwenbergh Director $6.4K Feb 17, 2023
Patricia A. Bradford Director $5.92K Sep 11, 2024
Curtis Lockshin Director $1.48K Sep 11, 2024
Jonathan E. Freeman Director $740 Sep 11, 2024

Recent Insider Transactions by Companies or Individuals for Phio Pharmaceuticals Corp.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.